Squarepoint’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,000
Closed -$107K 4950
2025
Q1
$107K Sell
13,000
-79,700
-86% -$669K ﹤0.01% 4201
2024
Q4
$766K Buy
92,700
+62,700
+209% +$503K ﹤0.01% 3324
2024
Q3
$230K Hold
30,000
﹤0.01% 3606
2024
Q2
$311K Hold
30,000
﹤0.01% 3407
2024
Q1
$358K Buy
+30,000
New +$333K ﹤0.01% 3273

Other funds holding PTEN

Squarepoint's PTEN Position: Q2 2026 in Review

Squarepoint reduced its Patterson-UTI (PTEN) stake by 65% in Q2 2026, selling an estimated $24.1M and leaving 1,172,547 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #1066.

Squarepoint first reported a position in PTEN in Q1 2016 and has held it in 33 quarters since. The position peaked at $36.1M in Q1 2026. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Squarepoint held 1,172,547 shares of Patterson-UTI worth $10.8M as of Q2 2026.
  • Squarepoint sold 2,163,953 Patterson-UTI shares in Q2 2026, an estimated $24.1M.
  • Patterson-UTI made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1066 holding.
  • Squarepoint first reported a position in Patterson-UTI in Q1 2016 and has held it in 33 quarters since.
  • Squarepoint's Patterson-UTI position peaked at $36.1M in Q1 2026.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.